1. Home
  2. BLRX vs CVU Comparison

BLRX vs CVU Comparison

Compare BLRX & CVU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLRX
  • CVU
  • Stock Information
  • Founded
  • BLRX 2003
  • CVU 1980
  • Country
  • BLRX Israel
  • CVU United States
  • Employees
  • BLRX N/A
  • CVU N/A
  • Industry
  • BLRX Biotechnology: Pharmaceutical Preparations
  • CVU Military/Government/Technical
  • Sector
  • BLRX Health Care
  • CVU Industrials
  • Exchange
  • BLRX Nasdaq
  • CVU Nasdaq
  • Market Cap
  • BLRX 36.0M
  • CVU 48.5M
  • IPO Year
  • BLRX 2011
  • CVU N/A
  • Fundamental
  • Price
  • BLRX $0.20
  • CVU $3.85
  • Analyst Decision
  • BLRX Strong Buy
  • CVU
  • Analyst Count
  • BLRX 2
  • CVU 0
  • Target Price
  • BLRX $5.50
  • CVU N/A
  • AVG Volume (30 Days)
  • BLRX 1.7M
  • CVU 38.0K
  • Earning Date
  • BLRX 11-25-2024
  • CVU 11-13-2024
  • Dividend Yield
  • BLRX N/A
  • CVU N/A
  • EPS Growth
  • BLRX N/A
  • CVU 86.98
  • EPS
  • BLRX N/A
  • CVU 1.37
  • Revenue
  • BLRX $21,991,000.00
  • CVU $82,814,085.00
  • Revenue This Year
  • BLRX N/A
  • CVU N/A
  • Revenue Next Year
  • BLRX N/A
  • CVU N/A
  • P/E Ratio
  • BLRX N/A
  • CVU $2.83
  • Revenue Growth
  • BLRX N/A
  • CVU N/A
  • 52 Week Low
  • BLRX $0.19
  • CVU $2.16
  • 52 Week High
  • BLRX $1.68
  • CVU $4.07
  • Technical
  • Relative Strength Index (RSI)
  • BLRX 25.94
  • CVU 57.91
  • Support Level
  • BLRX $0.23
  • CVU $3.78
  • Resistance Level
  • BLRX $0.56
  • CVU $4.07
  • Average True Range (ATR)
  • BLRX 0.03
  • CVU 0.19
  • MACD
  • BLRX 0.00
  • CVU 0.00
  • Stochastic Oscillator
  • BLRX 11.82
  • CVU 58.33

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

About CVU CPI Aerostructures Inc.

CPI Aerostructures Inc is engaged in the manufacturing of structural aircraft parts for fixed-wing aircraft and helicopters in both the commercial and defense markets in the United States. It also provides engineering, program management, supply chain management and kitting, and Maintenance Repair and Overhaul (MRO) services. CPI also acts as a subcontractor to prime aircraft manufacturers in the production of commercial aircraft parts. CPI Aero supplies the E-2D Advanced Hawkeye surveillance aircraft, the A-10 Thunderbolt attack jet, the Gulfstream G650, the UH-60 BLACK HAWK helicopter, and the S-92 helicopter and others.

Share on Social Networks: